Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02604745 · ClinicalTrials.gov registry record
Degenerative Mitral Regurgitation in Intermediate Risk Patients
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 13
- Enrollment target
NCT02604745: Completed study, sponsored by Northwestern University.
NCT02604745 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02604745 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The main objective of this project is to determine intermediate-term echocardiographic outcomes in Medicare eligible patients (65 years of age and older) with moderate surgical risk who have undergone mitral valve surgery for degenerative mitral regurgitation.
Primary Outcome
To evaluate exercise duration and workload (METS) in patients who have undergone mitral valve surgery for degenerative mitral regurgitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2016-03 |
| Est. Completion | 2021-01 |
What the finished NCT02604745 record still lists
NCT02604745 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02604745 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02604745 about?
NCT02604745 is a clinical study titled "Degenerative Mitral Regurgitation in Intermediate Risk Patients". The main objective of this project is to determine intermediate-term echocardiographic outcomes in Medicare eligible patients (65 years of age and older) with moderate surgical risk who have undergone mitral valve surgery for degenerative mitral regurgitation.
What is the current status of trial NCT02604745?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2016-03. Estimated completion is 2021-01.
Who is sponsoring clinical trial NCT02604745?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia